Pro-inflammatory transcriptional regulators

Pro-inflammatory transcriptional regulators are a broad class of proteins that orchestrate the cellular response to inflammatory stimuli by controlling the expression of genes involved in immunity and inflammation (Hayden & Ghosh, 2012, Genes & Dev). Major families within this group include Nuclear Factor-kappa B (NF-κB), Activator Protein-1 (AP-1), and Signal Transducer and Activator of Transcription (STAT) proteins (O'Shea & Plenge, 2012, Nat Rev Immunol). These regulators are typically sequestered in the cytoplasm or remain inactive until they receive signals from cell-surface receptors, such as Toll-like receptors (TLRs) or cytokine receptors. Upon activation, they undergo post-translational modifications or translocation to the nucleus, where they bind to specific promoter or enhancer regions to drive the production of cytokines, chemokines, and enzymes like COX-2 (Karin & Gallagher, 2005, Immunology). Chronic or aberrant activation of these pathways is central to the pathogenesis of rheumatoid arthritis, inflammatory bowel disease, and various malignancies (Libermann & Zerbini, 2006, Curr Gene Ther). Consequently, they are major targets for anti-inflammatory and immunosuppressive therapies, ranging from broad-acting corticosteroids to more selective kinase inhibitors.

Other names

Pro-inflammatory transcription factorsInflammatory gene regulatorsInflammatory transcriptional modulators

Drugs targeting these regulators typically function by inhibiting upstream activating kinases (e.g., JAK or IKK), preventing nuclear translocation through interaction with nuclear receptors, or interfering with DNA binding and the recruitment of co-activators, thereby suppressing the transcription of pro-inflammatory genes (Hayden & Ghosh, 2012, Genes & Dev; O'Shea & Plenge, 2012, Nat Rev Immunol).